Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a special ointment heal diabetic foot ulcers faster?

NCT ID NCT01070433

Disease control Sponsor: Skingenix, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a topical ointment called MEBO can safely and effectively heal diabetic foot ulcers compared to standard care. 75 adults with diabetic foot ulcers lasting at least 4 weeks took part. The main goal was to see if the ulcer healed completely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MEBO wound ointment
What this could lead to
If it works, this could provide a new topical treatment option to help heal diabetic foot ulcers more effectively.
What could go wrong
This is a small phase 2 trial with only 75 participants, so results may not apply to everyone. The ointment may not prove better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

75 people

The number who actually took part.

Start date

Sep 2012

Finished

Dec 2013

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female ≥18 years of age * Able and willing to provide informed consent * Able and willing to comply with protocol visits and procedures * Target ulcer duration of ≥4 weeks Exclusion Criteria: * Ulcer of a non-diabetic pathophysiology * Known or suspected allergies to any of the components of MEBO * Malignancy on target ulcer foot * Non-compliance in the screening or run-in period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot ulcers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot ulcers

Contacts and locations

Locations

  • Advanced Foot and Ankle Center

    Las Vegas, Nevada, 89119, United States

  • Center for Clinical Research, Inc.

    Castro Valley, California, 94546, United States

  • Complete Family Foot Care

    McAllen, Texas, 78501, United States

  • Endeavor Clinical Trials, San Antonio Podiatry Associates

    San Antonio, Texas, 78229, United States

  • Foot and Ankle Clinic

    Los Angeles, California, 90010, United States

  • HOPE Research Institute

    Phoenix, Arizona, 85032, United States

  • ILD Consulting, Inc.

    Encinitas, California, 92024, United States

  • Sacramento Foot and Ankle Center

    Fair Oaks, California, 95628, United States

  • Valley Vascular Surgery Associates

    Fresno, California, 93720, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.